down arrow

Aurobindo Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,095.40
37.45 (3.54%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.81 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Rs cr
Consolidate Quarterly Results
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Net Sales
7,978.52
7,796.07
7,567.02
7,580.15
7,351.78
7,219.42
6,850.52
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,978.52
7,796.07
7,567.02
7,580.15
7,351.78
7,219.42
6,850.52
Raw Material Cost
2,728.74
2,741.85
2,466.66
2,634.88
2,675.52
2,708.91
2,756.83
Purchase of Finished goods
823.89
747.03
680.01
785.95
775.75
631.07
580.16
(Increase) / Decrease In Stocks
-237.22
-278.61
-73.99
-359.95
-300.70
-103.24
-182.28
Employee Cost
1,131.55
1,109.48
1,071.95
1,026.32
989.68
954.97
951.97
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,953.58
1,910.18
1,802.82
1,820.14
1,610.22
1,654.27
1,592.47
Total Expenditure (Excl Depreciation)
6,400.54
6,229.93
5,947.45
5,907.34
5,750.47
5,845.98
5,699.15
Operating Profit (PBDIT) excl Other Income
1,577.98
1,566.14
1,619.57
1,672.81
1,601.31
1,373.44
1,151.37
Other Income
157.29
136.00
220.93
135.62
162.52
186.98
116.33
Operating Profit (PBDIT)
1,735.27
1,702.14
1,840.50
1,808.43
1,763.83
1,560.42
1,267.70
Interest
118.48
112.70
111.04
89.43
75.55
68.18
56.55
Exceptional Items
0.00
0.00
0.00
-122.11
0.00
0.00
-69.75
Gross Profit (PBDT)
1,616.79
1,589.44
1,729.46
1,596.89
1,688.28
1,492.24
1,141.40
Depreciation
418.53
382.28
404.18
354.33
423.27
417.50
326.56
Profit Before Tax
1,199.85
1,207.46
1,323.89
1,229.90
1,262.42
1,075.64
812.03
Tax
354.28
390.51
405.67
322.55
322.45
323.70
242.32
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
843.98
816.65
919.61
920.01
942.56
751.04
572.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
843.98
816.65
919.61
920.01
942.56
751.04
572.52
Share in Profit of Associates
1.59
0.30
-1.39
-12.66
-2.59
0.90
-2.81
Minority Interest
-0.24
-0.43
-1.00
-1.40
3.68
-5.24
-1.04
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
845.81
817.38
919.22
908.75
936.29
757.18
570.75
Equity Capital
58.08
58.08
58.59
58.59
58.59
58.59
58.59
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
30,820.31
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
14.56
14.07
15.69
15.51
15.98
12.92
9.74
Diluted Earnings per share
14.56
14.0
15.69
15.51
16.04
12.83
9.74
Operating Profit Margin (Excl OI)
19.99%
20.48%
21.72%
22.33%
22.02%
19.21%
16.96%
Gross Profit Margin
20.48%
20.79%
23.19%
21.31%
23.22%
20.87%
16.81%
PAT Margin
10.71%
10.68%
12.31%
12.11%
12.93%
10.52%
8.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2024 is 2.34% vs 3.03% in Sep 2024

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2024 is 3.48% vs -11.08% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is 0.76% vs -3.30% in Sep 2024

stock-summary

Interest

QoQ Growth in quarter ended Dec 2024 is 5.13% vs 1.49% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Aurobindo Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
7,978.52
3,230.00
4,748.52
147.01%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,978.52
3,230.00
4,748.52
147.01%
Raw Material Cost
2,728.74
536.11
2,192.63
408.99%
Purchase of Finished goods
823.89
387.30
436.59
112.73%
(Increase) / Decrease In Stocks
-237.22
11.81
-249.03
-2,108.64%
Employee Cost
1,131.55
709.71
421.84
59.44%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,953.58
755.27
1,198.31
158.66%
Total Expenditure (Excl Depreciation)
6,400.54
2,400.20
4,000.34
166.67%
Operating Profit (PBDIT) excl Other Income
1,577.98
829.80
748.18
90.16%
Other Income
157.29
77.32
79.97
103.43%
Operating Profit (PBDIT)
1,735.27
907.12
828.15
91.29%
Interest
118.48
220.93
-102.45
-46.37%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,616.79
686.19
930.60
135.62%
Depreciation
418.53
192.30
226.23
117.64%
Profit Before Tax
1,199.85
497.33
702.52
141.26%
Tax
354.28
112.81
241.47
214.05%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
843.98
381.08
462.90
121.47%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
843.98
381.08
462.90
121.47%
Share in Profit of Associates
1.59
3.44
-1.85
-53.78%
Minority Interest
-0.24
4.29
-4.53
-105.59%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
845.81
380.23
465.58
122.45%
Equity Capital
58.08
40.06
18.02
44.98%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
14.56
9.49
5.07
53.42%
Diluted Earnings per share
14.56
9.44
5.12
54.24%
Operating Profit Margin (Excl OI)
19.99%
25.69%
0.00
-5.70%
Gross Profit Margin
20.48%
21.24%
0.00
-0.76%
PAT Margin
10.71%
11.90%
0.00
-1.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 7,978.52 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 2.34% vs 3.03% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 8.53% vs 14.74% in Dec 2023

Quarterly - Consolidate Net Profit
Consolidate Net Profit 845.81 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 3.48% vs -11.08% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -9.66% vs 90.59% in Dec 2023

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,577.98 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 0.76% vs -3.30% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is -1.46% vs 67.78% in Dec 2023

Quarterly - Interest
Interest 118.48 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

QoQ Growth in quarter ended Dec 2024 is 5.13% vs 1.49% in Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 is 56.82% vs 68.04% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.99%
in Dec 2024

Figures in Rs %
stock-summary

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

stock-summary

YoY Growth in quarter ended Dec 2024 has fallen from Dec 2023